|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Maryland Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MarylandLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
GlycoMimetics, Inc.
| | | Phone: | (240) 243-1201 | Fax: | (240) 243-1018 | Year Established: | 2003 | Ticker: | GLYC | Exchange: | NASDAQ | Main Contact: | Rachel K. King, CEO | | Other Contacts: | Henry Flanner, VP, Technical Operations Armand Girard, VP, Corporate Development Brian Hahn, CFO John Magnani, Ph.D., Senior VP & CSO Helen Thackray, MD, FAAP, Senior VP, Drug Development & CMO
| | Company Description | GlycoMimetics is a clinical-stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. | |
|
|
|
|
|